Agilent and ABI look east
Both Agilent and Applied Biosystems (ABI) have announced new facilities in Asia and are looking to gain from the increasing pharmaceutical industry presence in the region.
Archives for March 23, 2007
Chaperone drugs show promising results
A new wave of drugs designed to treat rare brain disorders, which are caused when proteins don't fold correctly, are showing promising results in trials, according to their developer.
Eisai buy cancer antibody specialists
Japanese pharma firm Eisai has made a foray into biological drug discovery by buying a US company who specialise in cancer antibodies.
Drugs moving into the clinic: 7
The seventh in a series of periodic roundups of drugs that have moved from preclinical research into clinical testing via the announcement of a Phase I trial or an application for a trial to industry regulators.